Jynarque
Ended Awarded
- Contract number
- 36C26124N0495
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
On March 13, 2024, the Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded a $12,580.72 delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan). This firm-fixed price delivery order, with an ultimate completion date of June 13, 2024, is issued without a set-aside designation and represents a task order under the company's larger Indefinite Delivery Vehicle—a Blanket Purchase Agreement valued at $83.3 million for Jynarque. The contract falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is being performed in Potomac, Maryland.
Jynarque is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is an established federal contractor with significant pharmaceutical supply capabilities to the Veterans Health Administration across multiple VISNs. This delivery order supports the VA's mission to provide specialized pharmaceutical treatments to veterans and represents part of the company's ongoing relationship with the VA for critical medication supply through streamlined federal procurement mechanisms.
Quick answers
Who was awarded contract 36C26124N0495?
36C26124N0495 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 13, 2024.
How much is contract 36C26124N0495 worth?
The government has obligated $12,581 on 36C26124N0495.
Is contract 36C26124N0495 an order under another contract?
Yes. 36C26124N0495 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0495 competed?
The extent of competition for 36C26124N0495 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award